Flexion Therapeutics: Q1 Earnings Snapshot

·1 min read

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $28.6 million in its first quarter.

The Burlington, Massachusetts-based company said it had a loss of 57 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.

The specialty pharmaceutical companies that specializes in pain relief posted revenue of $24.6 million in the period, which met Street forecasts.

Flexion Therapeutics shares have declined 19% since the beginning of the year. The stock has dropped 25% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLXN at https://www.zacks.com/ap/FLXN

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting